- $380.87m
- $307.03m
- $101.02m
Carlsmed, Inc. reports results for the quarter ended June 30 - Earnings Summary
Carlsmed Q2 revenue rises 57%, raises 2026 revenue forecast
Carlsmed, Inc. expected to post a loss of 41 cents a share - Earnings Preview
Brief: Carlsmed Announces CMS Finalizes Favorable Reimbursement For aprevo Lumbar Procedures In FY2027
Carlsmed Q1 revenue jumps 58%, company raises 2026 outlook
Carlsmed Q4 revenue surges, driven by AI-enabled spine surgery solutions
Carlsmed's preliminary Q4 revenue rises 61% to $15.2 mln
Brief: Carlsmed® Reports Second Quarter 2025 Financial Results
Brief: Carlsmed® Reports Second Quarter 2025 Financial Results
Insurance marketplace Accelerant, backers raise $724 million in US IPO (updated)
U.S. STOCKS ON THE MOVE-Tesla, Northern Trust, General Dynamics
Spine surgery firm Carlsmed falls in Nasdaq debut after $101 million IPO
Brief: Carlsmed Announces Pricing Of Initial Public Offering At $15 Per Share
Brief: Carlsmed Announces Launch Of Initial Public Offering